How to lead a research team from #hackathon to plenary in 6 months
…continue reading the full story in The Cancer Letter and Q&A with Matthew Ong
Feature image credit: The Cancer Letter
Similar Posts
Do FDA Alerts Impact Practice Patterns?
Think about the last time you were forced to make a decision in the face of uncertainty. You may have been choosing which job offer to accept or whether to move from renting to buying a home. You probably weighed the tradeoffs and asked yourself whether it made sense to gather additional information or to…
Immunotherapy increasing at end of life
Our new study on the rise of immunotherapy drugs at the end of life with bladder cancer learned from real-world patients by using @flatironhealth curated EHR data. We hypothesized that advanced urothelial cancer patients would increasingly receive checkpoint inhibitors near the end of life, as they tend to have more favorable side effect profiles…
Age-based priority groups for efficient vaccination in South Africa
New paper in Vaccine shows staggered age targeting and the durability of protection will be key to strategic and efficient vaccination in South Africa. When an HIV vaccine is ready to launch in South Africa, an efficient implementation strategy needs to be ready. I worked with 3 women scientists in South Africa, 3 academic men…
How to Validate Forecasts
Let’s keep digging into the association between Google searches and the number of people starting PrEP drugs by fitting a poisson model of the time series in R. We’ll use this work-in-progress to kick off a discussion on validation of models used to forecast utilization. To review: First, we first noticed a similarity in the trends…
How should we evaluate ACA impact on HIV?
Lipira and colleagues recently published this comprehensive review article framing a research agenda to evaluate the impact of the Affordable Care Act (commonly called the “ACA” or “Obamacare”) on HIV care, outcomes, prevention, and disparities. Lipira and colleagues identified several challenges to comprehensive HIV care that could be remedied with informed programming and policy. First, the ACA does…
Should we pay some people to take their HIV drugs?
There is little prior evidence of effective interventions to improve viral suppression, despite this being a critical step in the HIV care continuum as described in the National HIV/AIDS Strategy for the United States.
